Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain.

The activity of c-Jun is regulated by phosphorylation. Various stimuli including transforming oncogenes and UV light, induce phosphorylation of serines 63 and 73 in the amino-terminal activation domain of c-Jun and thereby potentiate its trans-activation function. We identified a serine/threonine kinase whose activity is stimulated by the same signals that stimulate the amino-terminal phosphorylation of c-Jun. This novel c-Jun amino-terminal kinase (JNK), whose major form is 46 kD, binds to a specific region within the c-Jun trans-activation domain and phosphorylates serines 63 and 73. Phosphorylation results in dissociation of the c-Jun-JNK complex. Mutations that disrupt the kinase-binding site attenuate the response of c-Jun to Ha-Ras and UV. Therefore the binding of JNK to c-Jun is of regulatory importance and suggests a mechanism through which protein kinase cascades can specifically modulate the activity of distinct nuclear targets.

[1]  E. Elion,et al.  FUS3 phosphorylates multiple components of the mating signal transduction cascade: evidence for STE12 and FAR1. , 1993, Molecular biology of the cell.

[2]  J. Auwerx,et al.  Negative regulation of Jun/AP-1: conserved function of glycogen synthase kinase 3 and the Drosophila kinase shaggy. , 1993, Oncogene.

[3]  J. Woodgett,et al.  Co-purification of mitogen-activated protein kinases with phorbol ester-induced c-Jun kinase activity in U937 leukaemic cells. , 1993, Oncogene.

[4]  S. Jackson,et al.  The DNA-dependent protein kinase: Requirement for DNA ends and association with Ku antigen , 1993, Cell.

[5]  M. Karin,et al.  The mammalian ultraviolet response is triggered by activation of src tyrosine kinases , 1992, Cell.

[6]  H. Lu,et al.  Ku autoantigen is the regulatory component of a template-associated protein kinase that phosphorylates RNA polymerase II. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Nevins,et al.  E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. , 1992, Science.

[8]  M. Karin,et al.  Control of transcription factors by signal transduction pathways: the beginning of the end. , 1992, Trends in biochemical sciences.

[9]  J. Ferrell,et al.  Inhibition of c-Jun DNA binding by mitogen-activated protein kinase. , 1992, Molecular biology of the cell.

[10]  D. Luk,et al.  Jun is phosphorylated by several protein kinases at the same sites that are modified in serum-stimulated fibroblasts , 1992, Molecular and cellular biology.

[11]  D. Brenner,et al.  Casein kinase II is a negative regulator of c-Jun DNA binding and AP-1 activity , 1992, Cell.

[12]  Andrew J. Bannister,et al.  Conserved motifs in Fos and Jun define a new class of activation domain. , 1992, Genes & development.

[13]  A. Kraft,et al.  Affinity-purified c-Jun amino-terminal protein kinase requires serine/threonine phosphorylation for activity. , 1992, The Journal of biological chemistry.

[14]  Tony Hunter,et al.  The regulation of transcription by phosphorylation , 1992, Cell.

[15]  R. Tjian,et al.  The cell-type-specific activator region of c-Jun juxtaposes constitutive and negatively regulated domains. , 1992, Genes & development.

[16]  M. Karin,et al.  Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73 , 1992, Molecular and cellular biology.

[17]  A. Kraft,et al.  Phorbol esters stimulate the phosphorylation of c-Jun but not v-Jun: regulation by the N-terminal delta domain. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Y. Shaul,et al.  c-abl has a sequence-specific enhancer binding activity , 1992, Cell.

[19]  A. Rao,et al.  Nuclear factor of activated T cells contains Fos and Jun , 1992, Nature.

[20]  M. Karin,et al.  Fos and Jun repress transcriptional activation by myogenin and MyoD: the amino terminus of Jun can mediate repression. , 1992, Genes & development.

[21]  M. Pagano,et al.  Association of cdk2 kinase with the transcription factor E2F during S phase. , 1992, Science.

[22]  S. Tapscott,et al.  Functional antagonism between c-Jun and MyoD proteins: A direct physical association , 1992, Cell.

[23]  P. Vogt,et al.  Mutations in the Jun delta region suggest an inverse correlation between transformation and transcriptional activation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[24]  G. Thomas MAP kinase by any other name smells just as sweet , 1992, Cell.

[25]  J. Nevins,et al.  A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex , 1992, Cell.

[26]  L. Tsai,et al.  Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F , 1992, Nature.

[27]  M. Karin,et al.  Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73 , 1991, Nature.

[28]  M. Karin,et al.  The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. , 1991, Biochimica et biophysica acta.

[29]  M. Karin,et al.  Antagonism between retinoic acid receptors and AP-1: implications for tumor promotion and inflammation. , 1991, The New biologist.

[30]  P. Brown,et al.  The transactivating domain of the c-Jun proto-oncoprotein is required for cotransformation of rat embryo cells , 1991, Molecular and cellular biology.

[31]  James R. Woodgett,et al.  Phosphorylation of c-jun mediated by MAP kinases , 1991, Nature.

[32]  Nancy Y. Ip,et al.  ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF , 1991, Cell.

[33]  M. Karin,et al.  Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain , 1991, Nature.

[34]  B. Wasylyk,et al.  The c‐Ets oncoprotein activates the stromelysin promoter through the same elements as several non‐nuclear oncoproteins. , 1991, The EMBO journal.

[35]  Tsonwin Hai,et al.  Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Tony Hunter,et al.  Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity , 1991, Cell.

[37]  L. Cantley,et al.  Oncogenes and signal transduction , 1991, Cell.

[38]  R. Tjian,et al.  Control of c-Jun activity by interaction of a cell-specific inhibitor with regulatory domain δ: Differences between v- and c-Jun , 1990, Cell.

[39]  C. Chang,et al.  Efficient transformation of chicken embryo fibroblasts by c-Jun requires structural modification in coding and noncoding sequences. , 1990, Genes & development.

[40]  M. Karin,et al.  Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction , 1990, Cell.

[41]  K. Yamamoto,et al.  Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. , 1990, Science.

[42]  G. Fink,et al.  FUS3 encodes a cdc2+/CDC28-related kinase required for the transition from mitosis into conjugation , 1990, Cell.

[43]  P. Vogt,et al.  jun: oncogene and transcription factor. , 1990, Advances in cancer research.

[44]  M. Karin,et al.  Different requirements for formation of Jun: Jun and Jun: Fos complexes. , 1989, Genes & development.

[45]  R. Tjian,et al.  Biochemical analysis of transcriptional activation by Jun: Differential activity of c- and v-Jun , 1989, Cell.

[46]  I. Kameshita,et al.  A sensitive method for detection of calmodulin-dependent protein kinase II activity in sodium dodecyl sulfate-polyacrylamide gel. , 1989, Analytical biochemistry.

[47]  M. Ptashne,et al.  A vector for expressing GAL4(1-147) fusions in mammalian cells. , 1989, Nucleic acids research.

[48]  T. Sturgill,et al.  Evidence that pp42, a major tyrosine kinase target protein, is a mitogen-activated serine/threonine protein kinase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Michael R. Green,et al.  Transcription activation by the adenovirus E1a protein , 1989, Nature.

[50]  M. Karin,et al.  Jun and v-jun contain multiple regions that participate in transcriptional activation in an interdependent manner. , 1989, The New biologist.

[51]  L. M. Albright,et al.  Prokaryotic signal transduction mediated by sensor and regulator protein pairs. , 1989, Annual review of genetics.

[52]  Peter Angel,et al.  The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1 , 1988, Cell.

[53]  D. Smith,et al.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. , 1988, Gene.

[54]  B. Wasylyk,et al.  v-jun is a transcriptional activator, but not in all cell-lines. , 1988, Nucleic acids research.

[55]  F. Galibert,et al.  Identification in chickens of an evolutionarily conserved cellular ets‐2 gene (c‐ets‐2) encoding nuclear proteins related to the products of the c‐ets proto‐oncogene. , 1988, The EMBO journal.

[56]  R. Roeder,et al.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.